BioCentury | Sep 12, 2016
Strategy

Dealing Denali

Denali Therapeutics Inc .'s recent unveiling of 11 deals provides the first glimpse of how the company plans to deploy its nearly $350 million war chest to target neurodegenerative diseases. The company has previously said...
BioCentury | May 18, 2015
Finance

Planting Fidelity's seeds

Fidelity Biosciences Research Initiative has helped create a neurodegenerative disease company that could serve as a repository for the discoveries stemming from seed investments in academia that FBRI has quietly been making for the past...
BioCentury | May 15, 2015
Financial News

Denali's mountain of money

Neurodegenerative disease company Denali Therapeutics Inc. (San Francisco, Calif.) raised $217 million in an untranched series A round -- the second largest series A financing in the industry's history. Investors included Fidelity Biosciences; Arch Venture...
BioCentury | Nov 23, 2009
Company News

Cannasat management update

...Business: Drug delivery, Neurology Hired: Anthony Giovinazzo as president and CEO, formerly president of the Neuroscience Partners...
BioCentury | Oct 10, 2005
Finance

Ebb & Flow

...Forward Ventures (6.5%); Easton Hunt (6.4%); Cross Atlantic Partners (5.2%); TVM Life Sciences (5.2%); and MDS/Neuroscience Partners...
BioCentury | Mar 25, 2002
Finance

Neuro money

...Business Development Bank of Canada; Investissement Desjardins; T2C2; CDP Capital; Innovatech; Canadian Medical Discoveries Fund; Neuroscience Partners...
BioCentury | Mar 5, 2002
Financial News

Aegera raises C$17 million

...regional et cooperatif Desjardins; T2C2/Bio 2000; CDP Sofinov; Innovatech Grand Montreal; Canadian Medical Discovery Fund; Neuroscience Partners...
BioCentury | May 7, 2001
Finance

VCs rediscover neurology

...neuroscience funds, MDS Capital Corp. (Toronto, Ontario), has invested about 90% of its C$52.5 million Neuroscience Partners...
BioCentury | Jun 22, 1998
Finance

Centaur plans huge Swiss IPO

...Menlo Ventures IV, Bismuth Investments, Paul F. Glenn and the Glenn Foundation, Charter Ventures, and Neuroscience Partners...
BioCentury | Mar 16, 1998
Strategy

Giving the money back

...clinic, Wilcox estimated. The company is continuing its $1.25 million per year funding of Cambridge NeuroScience Partners...
Items per page:
1 - 10 of 14
BioCentury | Sep 12, 2016
Strategy

Dealing Denali

Denali Therapeutics Inc .'s recent unveiling of 11 deals provides the first glimpse of how the company plans to deploy its nearly $350 million war chest to target neurodegenerative diseases. The company has previously said...
BioCentury | May 18, 2015
Finance

Planting Fidelity's seeds

Fidelity Biosciences Research Initiative has helped create a neurodegenerative disease company that could serve as a repository for the discoveries stemming from seed investments in academia that FBRI has quietly been making for the past...
BioCentury | May 15, 2015
Financial News

Denali's mountain of money

Neurodegenerative disease company Denali Therapeutics Inc. (San Francisco, Calif.) raised $217 million in an untranched series A round -- the second largest series A financing in the industry's history. Investors included Fidelity Biosciences; Arch Venture...
BioCentury | Nov 23, 2009
Company News

Cannasat management update

...Business: Drug delivery, Neurology Hired: Anthony Giovinazzo as president and CEO, formerly president of the Neuroscience Partners...
BioCentury | Oct 10, 2005
Finance

Ebb & Flow

...Forward Ventures (6.5%); Easton Hunt (6.4%); Cross Atlantic Partners (5.2%); TVM Life Sciences (5.2%); and MDS/Neuroscience Partners...
BioCentury | Mar 25, 2002
Finance

Neuro money

...Business Development Bank of Canada; Investissement Desjardins; T2C2; CDP Capital; Innovatech; Canadian Medical Discoveries Fund; Neuroscience Partners...
BioCentury | Mar 5, 2002
Financial News

Aegera raises C$17 million

...regional et cooperatif Desjardins; T2C2/Bio 2000; CDP Sofinov; Innovatech Grand Montreal; Canadian Medical Discovery Fund; Neuroscience Partners...
BioCentury | May 7, 2001
Finance

VCs rediscover neurology

...neuroscience funds, MDS Capital Corp. (Toronto, Ontario), has invested about 90% of its C$52.5 million Neuroscience Partners...
BioCentury | Jun 22, 1998
Finance

Centaur plans huge Swiss IPO

...Menlo Ventures IV, Bismuth Investments, Paul F. Glenn and the Glenn Foundation, Charter Ventures, and Neuroscience Partners...
BioCentury | Mar 16, 1998
Strategy

Giving the money back

...clinic, Wilcox estimated. The company is continuing its $1.25 million per year funding of Cambridge NeuroScience Partners...
Items per page:
1 - 10 of 14